Novavax COVID-19 vaccine produces antibodies in small study

Maryland-based biotechnology company, Novavax, said on Tuesday its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to an early-stage study. President of Research and Development, Dr. Gregory Glenn told Reuters the experimental vaccine “looked good in animals. Now it looks really good in people."

Save videos for later by signing up or logging in

With "My Queue" you can quickly save videos to watch later.

To add an item to your queue just click the sign next to the video.

Once you've added a video visit "My Queue" to start watching!